Devat 2026 deals surpass 10 billion AED
The Dubai International Pharmaceutical and Technology Conference and Exhibition "DUPHAT 2026" is taking place with deals valued at 10.3 billion dirhams, as experts discussed the future of pharmacy amidst technological transformations and artificial intelligence. Participants emphasized that the pharmaceutical industry is no longer limited to traditional knowledge; instead, it requires integrating technology—particularly AI applications and personalized medicine—to improve patient outcomes and safety. The conference highlighted the importance of developing pharmacy practices to meet the demands of personalized medicine, promoting responsible AI use frameworks, and assessing how technology impacts the enhancement of healthcare and public health. Recommendations included integrating drug safety systems with digital oversight, advancing education and training for the future, ensuring patient data protection, and fostering collaboration among various stakeholders to translate scientific progress into tangible healthcare services.
Notice: This Is an AI-Generated Summary
Comments (0)